Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
about
Intron requirement for expression of the human purine nucleoside phosphorylase geneRecombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescueMutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblastsSignal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not requiredHuman cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemTyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactionsProdrug activation enzymes in cancer gene therapy.Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.Gene therapy for Parkinson's disease: review and update.Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity.Sustained delivery of erythropoietin in mice by genetically modified skin fibroblastsGene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector.Long-term production and delivery of human growth hormone in vivoHighly efficient and sustained gene transfer in adult neurons with a lentivirus vector.Adenoviral vectors: development and application.In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.Polymeric nanoparticles for gene delivery.Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapyRepression of retrovirus-mediated transgene expression by interferons: implications for gene therapyRas transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.Transcriptional activation and transformation by FosB protein require phosphorylation of the carboxyl-terminal activation domain.Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformationMutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected]Construction of retroviral vector carrying HSV-tk gene under control of human AFP enhancer core sequence and human pgk promotor.Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivoIntravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters.Strategies for the development of cell lines for ex vivo gene therapy in the central nervous system.Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.A human beta cell line with drug inducible excision of immortalizing transgenes.Immortalization of pig fibroblast cells by transposon-mediated ectopic expression of porcine telomerase reverse transcriptaseHost cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.
P2860
Q24604155-6D999E6E-8971-4995-A34C-6E008EF94415Q24802168-D48D9A5E-FE32-4B88-80A0-180CD65BAF3BQ28587864-35E75A41-E4A6-435B-849F-ECD71BA734DAQ28776784-09635905-6DA0-46E8-AB85-E63E548F6659Q30503430-E79A8698-A4E8-4E56-B0E2-F268C37C5AF0Q33705401-D29D62E9-2E0F-44FD-A048-138C8DE3C3B1Q33781921-6D463D94-0351-4F93-890C-EC1D843A70ECQ33888773-16C5980D-767C-4398-93B9-F55D63347AF9Q33937612-BF3E0D46-6EB8-47A7-9FE3-7785C1AE37DEQ33968115-FCC2D8E9-10BD-4DDC-94E8-32891E5180A9Q34066344-D29C8005-1AD0-4A17-80C0-FB6656F60E61Q34119491-5CDCD9A6-3C8A-4C2D-8787-25BCA63BBC4EQ34201134-4DE322D9-B51D-41B2-A5C7-EA8AD21E3B12Q34421635-20BBB42B-DEFB-436D-A59A-5ABEB37006A7Q34675871-AEA88343-DE8C-4E02-A494-41F595E71A4EQ35051812-B3D5BA59-B239-4B48-95F2-3CF08BF35F54Q35757133-CB23A39D-A572-4883-8A47-C820AC916949Q35888390-D5F58440-BD8B-41A2-AC5B-2FFB9ADB49FDQ35891440-F61ADF74-552F-4524-B75C-14299303BD32Q36179657-DD40DCB7-8F98-450A-8D11-8A35740AF706Q36299641-69444B8D-679E-4E59-A84A-8F604BB25285Q36460846-4F280B5B-461F-4C5A-B4DD-1CC6DDEDBB55Q36534906-484F4D49-22AE-4515-A14A-C6C0C13CCABBQ36548693-24B15C94-C9C6-47E5-B0BE-8E6CFCC3DF50Q36552538-07DBB60E-C345-4853-8862-BBCE483D6B98Q36567871-8B9DAA6E-4876-4A5B-B4ED-6F6E1693CAA8Q36680730-5CB1D7BC-E4CB-4625-B149-4C8485A73BDFQ36685985-09DA0262-7459-4C0B-90FF-F2E63C15EAF7Q36697916-C192A151-863E-4A50-B8F1-1180019B2668Q36700186-B0DEA0E7-6211-478F-A8EB-C610E83B43BAQ36757603-EA8F25FC-044C-410A-83F6-5DCFC13F2EDCQ37251114-70D707F9-68BC-4698-8BB7-5EA23B5874FEQ37300317-B2102447-A2BF-49D8-81D8-4251362B97C7Q37354891-09FB143B-6205-44AC-90DB-DA6D055588BAQ37374666-B0712614-6340-436B-AEB8-F9FF6A894C68Q37822930-E1BE36DC-3806-4431-9682-67D9CEF39027Q38358539-11B0FA70-DC6B-4040-95AC-034E01111745Q38791508-E970BA09-4B45-434B-8F9D-3D43BB385DCBQ38837779-D953E90C-EA93-437B-B7C1-86C50B6CF1C3Q39577188-DCD8CA1D-7569-45A7-AE83-72D9E958303A
P2860
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term in vivo expression o ...... in mouse fibroblast implants.
@en
Long-term in vivo expression o ...... in mouse fibroblast implants.
@nl
type
label
Long-term in vivo expression o ...... in mouse fibroblast implants.
@en
Long-term in vivo expression o ...... in mouse fibroblast implants.
@nl
prefLabel
Long-term in vivo expression o ...... in mouse fibroblast implants.
@en
Long-term in vivo expression o ...... in mouse fibroblast implants.
@nl
P2093
P2860
P356
P1476
Long-term in vivo expression o ...... in mouse fibroblast implants.
@en
P2093
Axelrod JH
Scharfmann R
P2860
P304
P356
10.1073/PNAS.88.11.4626
P407
P577
1991-06-01T00:00:00Z